Novartis’ Exforge could get lift from Norvasc patent decision

March 23 2007

Yesterday’s Federal Court decision invalidating Pfizer’s Norvasc (amlodipine besylate) could give an early boost to Novartis’ Exforge.

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.